Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations

Gewirtz, 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochem. Pharmacol., 57, 727, 10.1016/S0006-2952(98)00307-4 Venkatesh, 2020, Anthracyclines Chaires, 1990, Biophysical chemistry of the daunomycin-DNA interaction, Biophys. Chem., 35, 191, 10.1016/0301-4622(90)80008-U Ewer, 2004, Cardiac safety of liposomal anthracyclines, Semin. Oncol., 31, 161, 10.1053/j.seminoncol.2004.08.006 Alhowail, 2019, Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation, Toxicol. Mech. Methods, 29, 457, 10.1080/15376516.2019.1600086 Keeney, 2015, Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: insights into mechanisms of neurotoxicity following doxorubicin chemotherapy, Cancer Lett., 367, 157, 10.1016/j.canlet.2015.07.023 Gilbar, 2020, Inadvertent intrathecal administration of vincristine: time to finally abolish the syringe, J. Oncol. Pharm. Pract., 26, 263, 10.1177/1078155219880600 Qweider, 2007, Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report, J. Neurosurg. Spine, 6, 280, 10.3171/spi.2007.6.3.280 Mortensen, 1992, Inadvertent intrathecal injection of daunorubicin with fatal outcome, Med. Pediatr. Oncol., 20, 249, 10.1002/mpo.2950200315 Wu, 2005, The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species, Anti-Cancer Drugs, 16, 93, 10.1097/00001813-200501000-00014 Joshi, 1996, Increase in brain nitric oxide synthase activity in daunorubicin-treated rats, Pharmacol. Toxicol., 78, 99, 10.1111/j.1600-0773.1996.tb00188.x Mohamed, 2011, Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-α, iNOS and NF-κB, Brain Res. Bull., 86, 22, 10.1016/j.brainresbull.2011.07.001 Hasinoff, 2008, The use of dexrazoxane for the prevention of anthracycline extravasation injury, Expert Opin. Investig. Drugs, 17, 217, 10.1517/13543784.17.2.217 Gilbar, 2014, Intrathecal chemotherapy: potential for medication error, Cancer Nurs., 37, 299, 10.1097/NCC.0000000000000108 Pan, 2016, Transverse myelopathy occurring with intrathecal administration of methotrexate and cytarabine chemotherapy: a case report, Oncol. Lett., 11, 4066, 10.3892/ol.2016.4519 Tariq, 2018, Intrathecal methotrexate-induced necrotizing myelopathy: a case report and review of histologic features, Clin. Med. Insights Pathol., 11, 10.1177/1179555718809071 Teh, 2007, Transverse myelopathy following intrathecal administration of chemotherapy, Singap. Med. J., 48, e46 Schochet, 1968, Neuronal changes induced by intrathecal vincristine sulfate, J. Neuropathol. Exp. Neurol., 27, 645, 10.1097/00005072-196810000-00008 Gilbar, 2006, The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags, J. Oncol. Pharm. Pract., 12, 113, 10.1177/1078155206070448 Saha, 2016, Clinical presentation of inadvertent Intrathecal vincristine masquerading Guillain-Barre syndrome, Ind. J. Hematol. Blood Transfus., 32, 59, 10.1007/s12288-016-0666-y Wojciak, 2018, The death of an infant after the unfortunate intrathecal injection of vincristine, Clin. Pract., 15, 438 Bleck, 1991, Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses, Clin. Neuropharmacol., 14, 457, 10.1097/00002826-199110000-00011 Fernandez, 1998, Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention, J. Pediatr. Hematol. Oncol., 20, 587, 10.1097/00043426-199811000-00018 Zaragoza, 1995, Neurourologic consequences of accidental intrathecal vincristine: a case report, Med. Pediatr. Oncol., 24, 61, 10.1002/mpo.2950240114 Jackson, 1988, Amelioration of vincristine neurotoxicity by glutamic acid, Am. J. Med., 84, 1016, 10.1016/0002-9343(88)90306-3